Results 141 to 150 of about 59,240 (301)
Cannabis use in a Canadian long-term care facility: a case study
BMC GeriatricsBackground Following the legalization of cannabis in Canada in 2018, people aged 65 + years reported a significant increase in cannabis consumption.
Lynda G. Balneaves +6 more
doaj +1 more source
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption [PDF]
To date, 16 states have passed medical marijuana laws, yet very little is known about their effects. Using state-level data, we examine the relationship between medical marijuana laws and a variety of outcomes.
Anderson, D. Mark, Rees, Daniel I.
core
After long delays, access to cannabis for medical reasons is now allowed under new law. [PDF]
, 2019 Health Minister Simon Harris has today signed legislation to allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years.....
Finn, Christina
core
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era
Addiction, EarlyView.Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley +1 more source
Cannabis withdrawal among Indigenous inmates (2012-2014) [PDF]
, 2012 [Extract] Cannabis Withdrawal Syndrome' is proposed for inclusion in the DSM-5 due for release in 2013. Problematic cannabis use in remote Indigenous communities has been reported in Northern Territory and Queensland studies.
Rogerson, Bernadette, Clough, Alan
core
Addiction, EarlyView.Abstract Background and aims Currently, there is no data‐driven cannabis reduction metric using biochemical verification, which represents a significant gap in cannabis harm reduction research, treatment and policy. Using aggregated data from 7 cannabis use disorder treatment trials, the aims of this analysis were to 1) determine if decreases in self ...
Erin A. McClure +6 more
wiley +1 more source
Varenicline for cannabis use disorder: A randomized controlled trial
Addiction, EarlyView.Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark +8 more
wiley +1 more source
Cannabis products: medical use
Revista da Associação Médica Brasileira, 2023 César Eduardo Fernandes +9 more
openaire +3 more sources
Medical Cannabis Expectancies Questionnaire [PDF]
, 2018 The current study details the development and psychometric evaluation of the Medical Cannabis Expectancy Questionnaire (MCEQ), a novel measure of the positive and negative effects that users anticipate experiencing after using combustible, vaporizable ...
Butler, Ellyn R.
core
Addiction, Volume 120, Issue 4, Page 686-687, April 2025.
Rachel Lees Thorne, Tom P. Freeman
wiley +1 more source